Oct 9, 2026 08:00PM
Aug 6, 2026 06:57AM
Aug 5, 2026 04:01PM
Jul 29, 2026 06:30AM
Jul 29, 2026 06:30AM
Jul 27, 2026 06:49AM
Jul 24, 2026 06:35AM MannKind raises $50M in private placement led by Frazier Life Sciences
Jul 24, 2026 06:35AM
Jul 24, 2026 06:30AM
Jul 24, 2026 06:30AM
Jun 23, 2026 09:00AM
Jun 23, 2026 09:00AM
Jun 5, 2026 07:35PM
Jun 3, 2026 06:05AM MannKind completes randomization in phase 1b study for IPF treatment
Jun 3, 2026 06:05AM
May 29, 2026 02:00PM
May 29, 2026 02:00PM
May 29, 2026 12:44PM
May 29, 2026 12:30PM
May 29, 2026 12:30PM
May 27, 2026 09:06AM MannKind presents Afrezza data at diabetes conference
May 27, 2026 09:05AM
May 6, 2026 06:31AM
May 6, 2026 06:30AM
Mar 9, 2026 09:05AM
Mar 9, 2026 09:05AM
Feb 26, 2026 08:00AM
Feb 9, 2026 06:10AM MannKind (MNKD) Announces First Patient Enrolled in INHALE-1ST Pediatric Study Evaluating Afrezza® for Youth with Newly-Diagnosed Type 1 Diabetes (T1D)
Feb 9, 2026 06:05AM
Jan 27, 2026 08:33AM
Jan 26, 2026 06:05AM
Jan 26, 2026 06:05AM
Jan 23, 2026 12:56PM
Jan 8, 2026 08:08AM
Jan 8, 2026 08:05AM MannKind Provides Business Updates and 2026 Growth Drivers
Dec 23, 2025 08:06AM
Dec 23, 2025 08:05AM
Dec 1, 2025 08:05AM
Dec 1, 2025 08:05AM
Nov 5, 2025 08:00AM
Oct 13, 2025 08:05AM
Oct 13, 2025 08:05AM MannKind Announces U.S. FDA Accepts for Review its Supplemental Biologics License Application (sBLA) for Inhaled Insulin (Afrezza) in Children and Adolescents Aged 4-17 Years Living with Diabetes
Sep 3, 2025 06:44AM
Aug 27, 2025 08:06AM
Aug 27, 2025 08:05AM
Aug 25, 2025 07:30AM
Aug 25, 2025 07:30AM
Aug 6, 2025 07:05AM
May 8, 2025 08:05AM MannKind Corporation Reports First Quarter 2025 Financial Results and Provides Business Update
Apr 12, 2025 04:00AM

333,560 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All